Brief: LTR Pharma Signs Collaborative Agreement To Develop OMD Nasal Spray
08/05/2025 02:23
May 8 (Reuters) - LTR Pharma Ltd LTP.AX: LTR SIGNS COLLABORATIVE AGREEMENT TO DEVELOP OMD NASAL SPRAY AGREEMENT WITH STRATEGIC DRUG SOLUTIONS, INC Further company coverage: LTP.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ltr Pharma
See all newsAustralia's LTR Pharma surges as its drug begins US prescription fulfillment
Brief: LTR Pharma Executes Exclusive Pilot Agreement With Marius Pharmaceuticals, Inc For Kyzatrex
Brief: LTR Pharma Executes U.S. Commercial Agreement With Strive
Australia's LTR Pharma rises on commercial tie-up with US telehealth firm
Australia's LT Pharma gains after nod to test nasal spray